Disclosing drug companies payments should be compulsory, say top earnersBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3716 (Published 04 July 2016) Cite this as: BMJ 2016;354:i3716
Read all the latest BMJ articles on Disclosure UK and view the linked infographics here.
- Duncan Jarvies
- The BMJ
The doctors who declared the most earnings from drug companies in the United Kingdom’s new database have said that being transparent about payments should be mandatory.
The database showed that 70% of healthcare professionals who received payments from drug companies agreed to have the information disclosed on Disclosure UK (www.disclosureuk.org.uk), which is hosted by the Association of the British Pharmaceutical Industry. But the 30% who didn’t agree to disclosure received more than half (52%) of the payments registered.1
From the data posted it is possible to find the top earners, but because of the way that the undeclared data are presented it is not possible to tell how they rank overall.
Ian Pavord, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial